Real World Efficacy of 1st-Line Nivolumab Plus Ipilimumab and its Practical Predictive Biomarkers in Advanced Renal Cell Carcinoma: First Analysis from RENOIR Study (KCSG GU22-13)
First-line NI showed comparable and competent efficacy in Korean patients with aRCC. We suggest completing full exposure to ipilimumab and durable response as practical predictors of enriched benefits of NI in our real-world.
Authors
- Joo Han Lim (ORCID: https://orcid.org/0000-0002-5330-1996)
- Jwa Hoon Kim (ORCID: https://orcid.org/0000-0002-0838-0111)
- Mihong Choi (ORCID: https://orcid.org/0000-0001-5576-7610)
- Jungmin Jo (ORCID: https://orcid.org/0000-0002-9322-7540)
- Hyo Jin Lee (ORCID: https://orcid.org/0000-0003-1746-7718)
- Hyeon-Su Im (ORCID: https://orcid.org/0000-0002-1393-4246)
- Dalyong Kim (ORCID: https://orcid.org/0000-0003-0193-422X)
- Byeong Seok Sohn (ORCID: https://orcid.org/0000-0002-6294-9591)
- Inkeun Park
- Kyoungmin Lee (ORCID: https://orcid.org/0000-0002-6578-7671)
- Sang Joon Shin (ORCID: https://orcid.org/0000-0001-5350-7241)
- Kwonoh Park (ORCID: https://orcid.org/0000-0002-7404-1257)
- Jin Young Kim (ORCID: https://orcid.org/0000-0002-9597-9834)
- In-Ho Kim (ORCID: https://orcid.org/0000-0003-1339-3459)
- Hyunho Kim (ORCID: https://orcid.org/0000-0003-1276-713X)
- Ji Hyun Park (ORCID: https://orcid.org/0000-0002-3552-7828)
- Il Hwan Kim (ORCID: https://orcid.org/0000-0003-4166-6303)
- Hyo‐Jeong Kim (ORCID: https://orcid.org/0000-0002-2180-891X)
- Eo Jin Kim (ORCID: https://orcid.org/0000-0001-9475-6930)
- Se Hyun Kim (ORCID: https://orcid.org/0000-0001-7078-2835)
- Woo Kyun Bae
Institutions
- Chonnam National University (KR)
- Ulsan College (KR)
- Inha University (KR)
- Yonsei University (KR)
- Chungnam National University (KR)
- Korea University Medical Center (KR)
- Asan Medical Center (KR)
- Seoul National University Bundang Hospital (KR)
- University of Ulsan (KR)
- Konkuk University Medical Center (KR)
- The Catholic University of Korea St. Vincent's Hospital (KR)
- Dongwha Pharm (South Korea) (KR)
- Inje University Haeundae Paik Hospital (KR)
- Kangbuk Samsung Hospital (KR)
- Dongguk University Ilsan Hospital (KR)
- The Catholic University of Korea Uijeongbu St. Mary's Hospital (KR)
- Maryknoll Medical Center (KR)
- Inje University Sanggye Paik Hospital (KR)
- Ulsan University Hospital (KR)
- Hanyang University Seoul Hospital (KR)
- Hanyang University Medical Center (KR)
- The Catholic University of Korea Seoul St. Mary's Hospital (KR)
- Korea University (JP)
- Keimyung University (KR)
- Sungkyunkwan University (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- Cancer Research and Treatment
- Published
- 2025-10-13
- DOI
- https://doi.org/10.4143/crt.2025.846
- Primary Topic
- Renal cell carcinoma treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00